
Stevanato Group S.p.A. (NYSE:STVN – Free Report) – Research analysts at William Blair decreased their Q4 2025 earnings per share estimates for Stevanato Group in a research report issued on Friday, November 7th. William Blair analyst M. Larew now anticipates that the company will earn $0.21 per share for the quarter, down from their prior estimate of $0.22. The consensus estimate for Stevanato Group’s current full-year earnings is $0.50 per share. William Blair also issued estimates for Stevanato Group’s Q3 2026 earnings at $0.20 EPS and FY2026 earnings at $0.75 EPS.
Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stevanato Group in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Stevanato Group currently has an average rating of “Moderate Buy”.
Stevanato Group Stock Performance
Shares of STVN opened at €24.37 on Monday. The company has a quick ratio of 1.30, a current ratio of 1.89 and a debt-to-equity ratio of 0.26. Stevanato Group has a 52-week low of €17.49 and a 52-week high of €28.00. The stock has a 50 day moving average price of €25.40 and a 200 day moving average price of €24.26. The company has a market capitalization of $7.38 billion, a price-to-earnings ratio of 42.76, a price-to-earnings-growth ratio of 2.38 and a beta of 0.56.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Invesco Ltd. purchased a new position in shares of Stevanato Group during the 1st quarter worth $19,072,000. Champlain Investment Partners LLC purchased a new position in Stevanato Group during the first quarter worth about $15,741,000. Ranger Investment Management L.P. boosted its stake in Stevanato Group by 125.6% in the 2nd quarter. Ranger Investment Management L.P. now owns 1,321,030 shares of the company’s stock worth $32,273,000 after buying an additional 735,417 shares during the last quarter. MetLife Investment Management LLC purchased a new stake in Stevanato Group in the 1st quarter valued at about $12,944,000. Finally, Loomis Sayles & Co. L P acquired a new position in shares of Stevanato Group during the 2nd quarter valued at about $13,729,000.
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles
- Five stocks we like better than Stevanato Group
- How to Read Stock Charts for Beginners
- Insiders Sold Big at These 3 Stocks—Should You Worry?
- How to Invest in Insurance Companies: A Guide
- Shares Down, Price Targets Up: 3 Stocks Upgraded After +10% Drops
- Airline Stocks – Top Airline Stocks to Buy Now
- Nuclear Stocks Are Melting Down—Should Investors Panic?
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
